5T6P | Immune System | date | Sep 01, 2016 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Therapeutic Mab Ar20.5 In Complex With Peptide | ||||||||||||||
authors | C.L.Brooks, M.Movahedin | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Fab Fragment Ar20.5 - Light Chain Chain: A, C Fragment: Antibody Fab Fragment Engineered: Yes |
Organism_scientific: Mus Musculus Organism_taxid: 10090 Expression_system: Mus Musculus Expression_system_taxid: 10090 Expression_system_cell_line: Hybridoma, Ar20.5 | ||||||||||||||
Molecule: Fab Fragment - Heavy Chain Chain: B, D Fragment: Muc1 Peptide Apdtrpap Engineered: Yes |
Organism_scientific: Mus Musculus Organism_taxid: 10090 Expression_system: Mus Musculus Expression_system_taxid: 10090 Expression_system_cell_line: Hybridoma Ar20.5 | ||||||||||||||
Molecule: Muc1 Peptide Fragment Chain: E, F Engineered: Yes |
Synthetic: Yes Organism_scientific: Homo Sapiens Organism_taxid: 9606 | ||||||||||||||
symmetry | Space Group: P 31 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.97 Å | ||||||||||||
Primary reference | Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen., Movahedin M, Brooks TM, Supekar NT, Gokanapudi N, Boons GJ, Brooks CL, Glycobiology. 2016 Dec 26. pii: cww131. doi: 10.1093/glycob/cww131. PMID:28025250 |
Data retrieval |
View 5T6P in 3D |
Visual 3D analysis of 5T6P |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5T6P |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |